Literature DB >> 10321465

Characterization of the hypnotic properties of oleamide.

A S Basile1, L Hanus, W B Mendelson.   

Abstract

While preliminary studies associated oleamide with sleep regulation, we now characterize the involvement of oleamide in sleep using a number of techniques. Peripheral administration of oleamide to rats dose dependently suppressed motor activity in the open field, with an ED50 of 17+/-1.5mg/kg for the decrease in distance traveled. Moreover, endogenous oleamide concentrations increased 3- to 4-fold in the cerebrospinal fluid of rats sleep-deprived for 6 h or longer. Oleamide also decreased sleep latency to 44-64% of control values without altering other sleep parameters. Unlike many putative endogenous sleep-inducing agents, oleamide potently induces behavioral and electroencephalographic manifestations of sleep. Moreover, its endogenous concentrations and temporal associations are consistent with previous reports of its enhancement of serotonergic and GABAergic neurotransmission, which may be involved in sleep induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321465     DOI: 10.1097/00001756-199904060-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

Authors:  Laura E Wise; Roberta Cannavacciulo; Benjamin F Cravatt; Billy F Martin; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2007-06-22       Impact factor: 5.250

2.  Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

Authors:  D L Boger; H Sato; A E Lerner; M P Hedrick; R A Fecik; H Miyauchi; G D Wilkie; B J Austin; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond.

Authors:  Mauro W Zappaterra; Maria K Lehtinen
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

6.  The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro.

Authors:  Leanne Coyne; George Lees; Russell A Nicholson; Jian Zheng; Katherine D Neufield
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH).

Authors:  Xiaoshan Min; Stephen T Thibault; Amy C Porter; Darin J Gustin; Timothy J Carlson; Haoda Xu; Michelle Lindstrom; Guifen Xu; Craig Uyeda; Zhihua Ma; Yihong Li; Frank Kayser; Nigel P C Walker; Zhulun Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

8.  Stereoselective modulatory actions of oleamide on GABA(A) receptors and voltage-gated Na(+) channels in vitro: a putative endogenous ligand for depressant drug sites in CNS.

Authors:  B Verdon; J Zheng; R A Nicholson; C R Ganelli; G Lees
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.

Authors:  Jing-Yu Yang; Chun-Fu Wu; Fang Wang; Hong-Rui Song; Wen-Jun Pan; Yu-Ling Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-13       Impact factor: 3.000

10.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice.

Authors:  P B Hedlund; P E Danielson; E A Thomas; K Slanina; M J Carson; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.